Levora Kit
Product Images NDC 51862-097

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Levora (NDC 51862-097). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mayne Pharma Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Levora 01)

Chemical structure diagram of levonorgestrel, the active ingredient in Levora. The structure shows the steroid backbone with functional groups relevant to its contraceptive activity.*

FDA Label Image

Chemical Structure (Levora 02)

Chemical structure diagram of the active ingredient levonorgestrel in the Levora prescription drug kit by Mayne Pharma Inc. The diagram illustrates the steroid backbone and functional groups characteristic of levonorgestrel.*

FDA Label Image

Table Ii (Levora 03)

A horizontal bar chart showing the number of women with a blood clot per 10,000 women years (WY) across four groups: Non-Pregnant Non-COC users (1 to 5), COC users (3 to 9), Pregnant women (5 to 20), and postpartum women within 12 weeks (40 to 65). The chart provides a comparative risk range for each group with postpartum women having the highest range.*

FDA Label Image

Levora 03a

A forest plot showing effect estimates (odds ratios or relative risks) with confidence intervals from various epidemiological studies related to combined oral contraceptive (COC) use. The studies are listed on the left, with comparisons for ever use and current use of COCs. The horizontal axis represents the effect estimate, ranging from -1.5 to 2, with a reference line at 1. Key abbreviations RR, OR, and HR are defined below the plot, along with an explanation of 'ever COC' and 'never COC' user groups.*

FDA Label Image

Blister Pack (Levora 04)

A vertical chart illustrating pregnancy rates per 100 women per year associated with various birth control methods. The chart ranks methods from fewer than 1 pregnancy (implants, injections, intrauterine devices, sterilization) to more than 85 pregnancies (no birth control) with intermediate methods such as birth control pills, skin patch, vaginal rings, condoms, diaphragm, and less effective methods like no sex during fertile days, spermicide, and withdrawal.*

FDA Label Image

Levora 04a

Levora 0.15/30 oral contraceptive tablet kit label showing a 28-day calendar layout with circles for each day of the week from Sunday to Saturday. The label includes dosing instructions with arrows to follow daily and indicates inactive tablets for the last week. The active ingredients, levonorgestrel 0.15 mg and ethinyl estradiol 0.03 mg, appear on the label along with the product NDC 51862-097-01 and monthly blister pack orientation.*

FDA Label Image

Principal Display Panel (Kit Carton)

Packaging label for Levora 0.15/30-28, a kit containing levonorgestrel and ethinyl estradiol tablets USP, 0.15 mg/0.03 mg. The label states a 28-day regimen with 6 blister cards holding 28 tablets each. It is labeled Rx only, distributed by Mayne Pharma Inc. The packaging includes storage instructions and a barcode, with the product noted as made in Canada.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.